• Like
  • Comment
  • Favorite

Stock Track | BioNTech Stock Plunges 5.2% on Concerns Over Trump's Anti-Vaccine Pick for Health Secretary

Stock Track11-15

BioNTech SE (BNTX), a leading producer of COVID-19 vaccines, saw its stock plummet 5.2% in the pre-market trading session on Friday, November 15, 2024. This sharp decline came after President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services (HHS).

Kennedy, known for his vocal criticism of childhood vaccinations and federal health agencies, has raised concerns among investors about the potential impact on the vaccine industry. His appointment as the head of HHS has sparked fears of reduced public trust in vaccines, lower vaccination rates, and a potential resurgence of preventable diseases.

Trump's comments that he would allow Kennedy to "go wild" on health issues have further fueled uncertainty surrounding the future direction of vaccine policies and regulations under the new administration. Investors are wary of the potential negative effects on vaccine demand, sales, and the overall business environment for companies like BioNTech.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial